These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1056 related articles for article (PubMed ID: 28040437)

  • 61. Endothelium-derived nitric oxide (NO) activates the NO-epidermal growth factor receptor-mediated signaling pathway in bradykinin-stimulated angiogenesis.
    Moraes MS; Costa PE; Batista WL; Paschoalin T; Curcio MF; Borges RE; Taha MO; Fonseca FV; Stern A; Monteiro HP
    Arch Biochem Biophys; 2014 Sep; 558():14-27. PubMed ID: 24960080
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pro-angiogenic activity of notoginsenoside R1 in human umbilical vein endothelial cells in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo.
    Yang BR; Hong SJ; Lee SM; Cong WH; Wan JB; Zhang ZR; Zhang QW; Zhang Y; Wang YT; Lin ZX
    Chin J Integr Med; 2016 Jun; 22(6):420-9. PubMed ID: 25533511
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cilostazol improves high glucose-induced impaired angiogenesis in human endothelial progenitor cells and vascular endothelial cells as well as enhances vasculoangiogenesis in hyperglycemic mice mediated by the adenosine monophosphate-activated protein kinase pathway.
    Tseng SY; Chao TH; Li YH; Liu PY; Lee CH; Cho CL; Wu HL; Chen JH
    J Vasc Surg; 2016 Apr; 63(4):1051-62.e3. PubMed ID: 25595409
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anti-angiogenic effect of tanshinone IIA involves inhibition of the VEGF/VEGFR2 pathway in vascular endothelial cells.
    Xing Y; Tu J; Zheng L; Guo L; Xi T
    Oncol Rep; 2015 Jan; 33(1):163-70. PubMed ID: 25376085
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antrodia cinnamomea produces anti-angiogenic effects by inhibiting the VEGFR2 signaling pathway.
    Huang TT; Lan YW; Ko YF; Chen CM; Lai HC; Ojcius DM; Martel J; Young JD; Chong KY
    J Ethnopharmacol; 2018 Jun; 220():239-249. PubMed ID: 29609012
    [TBL] [Abstract][Full Text] [Related]  

  • 66. PAC-1 and its derivative WF-210 Inhibit Angiogenesis by inhibiting VEGF/VEGFR pathway.
    Wang F; Wang L; Li Y; Wang N; Wang Y; Cao Q; Gong P; Yang J; Wu C
    Eur J Pharmacol; 2018 Feb; 821():29-38. PubMed ID: 29269017
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Curcumolide, a unique sesquiterpenoid from Curcuma wenyujin displays anti-angiogenic activity and attenuates ischemia-induced retinal neovascularization.
    Lin W; Tu H; Zhu Y; Guan Y; Liu H; Ling W; Yan P; Dong J
    Phytomedicine; 2019 Nov; 64():152923. PubMed ID: 31450226
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Effects and mechanisms of Xiao-Ai-Ping injection on angiogenesis].
    Wang MJ; Du DY; Fan W; Zhang C; Liu Y; Fan JH; Yuan ST; Lin SS
    Yao Xue Xue Bao; 2016 Feb; 51(2):309-15. PubMed ID: 29856586
    [TBL] [Abstract][Full Text] [Related]  

  • 69. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Extracellular taurine induces angiogenesis by activating ERK-, Akt-, and FAK-dependent signal pathways.
    Baek YY; Cho DH; Choe J; Lee H; Jeoung D; Ha KS; Won MH; Kwon YG; Kim YM
    Eur J Pharmacol; 2012 Jan; 674(2-3):188-99. PubMed ID: 22130357
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Oroxyloside inhibits angiogenesis through suppressing internalization of VEGFR2/Flk-1 in endothelial cells.
    Zhao K; Li X; Lin B; Yang D; Zhou Y; Li Z; Guo Q; Lu N
    J Cell Physiol; 2018 Apr; 233(4):3454-3464. PubMed ID: 28926106
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Vascular disrupting activity of combretastatin analogues.
    Porcù E; Salvador A; Primac I; Mitola S; Ronca R; Ravelli C; Bortolozzi R; Vedaldi D; Romagnoli R; Basso G; Viola G
    Vascul Pharmacol; 2016 Aug; 83():78-89. PubMed ID: 27235861
    [TBL] [Abstract][Full Text] [Related]  

  • 73. MiR-383 inhibits proliferation, migration and angiogenesis of glioma-exposed endothelial cells in vitro via VEGF-mediated FAK and Src signaling pathways.
    Zhao LN; Wang P; Liu YH; Cai H; Ma J; Liu LB; Xi Z; Li ZQ; Liu XB; Xue YX
    Cell Signal; 2017 Jan; 30():142-153. PubMed ID: 27693218
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis.
    Lin YC; Chao TY; Yeh CT; Roffler SR; Kannagi R; Yang RB
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):144-155. PubMed ID: 27834687
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Centchroman regulates breast cancer angiogenesis via inhibition of HIF-1α/VEGFR2 signalling axis.
    Dewangan J; Kaushik S; Rath SK; Balapure AK
    Life Sci; 2018 Jan; 193():9-19. PubMed ID: 29196053
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis.
    Dong F; Zhou X; Li C; Yan S; Deng X; Cao Z; Li L; Tang B; Allen TD; Liu J
    Cancer Biol Ther; 2014; 15(11):1479-88. PubMed ID: 25482945
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Arnebin-1 promotes angiogenesis by inducing eNOS, VEGF and HIF-1α expression through the PI3K-dependent pathway.
    Zeng Z; Huang WD; Gao Q; Su ML; Yang YF; Liu ZC; Zhu BH
    Int J Mol Med; 2015 Sep; 36(3):685-97. PubMed ID: 26202335
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation.
    Cho SG; Yi Z; Pang X; Yi T; Wang Y; Luo J; Wu Z; Li D; Liu M
    Cancer Res; 2009 Sep; 69(17):7062-70. PubMed ID: 19671799
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Jaceosidin, a natural flavone, promotes angiogenesis via activation of VEGFR2/FAK/PI3K/AKT/NF-κB signaling pathways in endothelial cells.
    Lee TH; Jung H; Park KH; Bang MH; Baek NI; Kim J
    Exp Biol Med (Maywood); 2014 Oct; 239(10):1325-34. PubMed ID: 24939823
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway.
    Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ
    Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.